This could explain some of it today. The article essentially blames the FDA for not moving quicker on a 'real' decision for CBD products. The article is verbose so I included the highlights of it:
A spate of new class-action lawsuits threaten the CBD industry. Will they force Washington to act?
In two major lawsuits recently filed against Charlotte’s Web and CV Sciences, two of the largest CBD manufacturers in the country, consumers allege that the companies engaged in “false, fraudulent, unfair, deceptive, and misleading” marketing of their CBD products by claiming they were run-of-the-mill dietary supplements, like vitamin D or iron.
If the companies lose the lawsuits, he said, “I’m not going to say [the CBD industry] goes away, but I think it gets pretty close to going away.”
There’s no telling yet who will prevail in these class-action lawsuits.
The FDA has already warned consumers that it is currently illegal to label CBD products as dietary supplements. The companies are accused of doing just that.
But the consumers don’t have a foolproof case either. The legality of CBD products isn’t settled: While the FDA has warned consumers about these products, it hasn’t released a formal policy on the topic, and it’s made clear it’s still working on setting that policy.
Fabricant, the head of the dietary supplement trade group, called the odds of the case 50-50.
Others were a bit more bullish for the CBD companies.
News 
Market Data 
Discover 
AI
